Explore the Latest News
Featured On
Let's Connect
If you're a member of the media and would like to talk, please get in touch with us via an email to
press@nanome.ai
Press Releases
-
San Diego-based virtual reality startup becomes first US-based company to join EU government supercomputing efforts against SARS-CoV-2
Nanome Inc., a virtual reality software startup, has joined Exscalate4Cov (E4C), a coordinated supercomputing project funded by the European Union (EU) Commission to screen chemical libraries for potential activity against SARS-CoV-2 (the coronavirus that causes COVID-19). E4C has €3 million of emergency EU funding and has already tested 9,000 drugs and bioactives, more than 100 of which have been found to be active in vitro.
-
Scientists Use Virtual Reality to Refine New AI-Generated Drugs for COVID-19
Nanome, Inc., a virtual reality (VR) startup whose signature product is a computational chemistry software platform, has co-authored a paper describing 10 potential small molecule inhibitors targeting the SARS-CoV-2 main protease that were generated by artificial intelligence (AI). The study was conducted in collaboration with Insilico Medicine, an artificial intelligence company based in Hong Kong, and could reveal as-yet-undiscovered methods for attacking the virus that have eluded scientists working with existing drug candidates.
-
Nanome Partners with Science Exchange to Offer Virtual Reality Drug Design Tools and Blockchain Solutions to Scientists
Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D) services, announced a partnership with Nanome Inc. to offer scientists on-demand access to Nanome’s blockchain and virtual reality technology.
-
Airbitz Rebrands, Partners with Matryx to Bring Digital Token to Virtual Reality
Edge (formerly Airbitz), is bringing blockchain to virtual reality in a new partnership with Matryx, a platform for decentralized collaboration currently based on the UC San Diego campus. Matryx, which is a project of the biotechnology firm Nanome Inc., will use Edge technology as a secure identity framework on its multiple virtual-reality-for-science platforms.
Recent Coverage
-
How virtual reality and high-performance scientific computing are helping scientists understand how COVID-19 behaves
On Thursday February 20th, Dr Michael Kuiper stepped into cryo-EM 2019-nCoV spike protein structure of COVID-19. The virus had infiltrated a protein within its host, utilising its uniquely virulent composition to take over
-
How Two VIVE X Companies are Helping Students and Researchers Learn Remotely
Introduces two Vive X companies facilitating remote learning, including Nanome
-
The Coronavirus and Virtual Reality
An overview of COVID-19's impact on VR industry, including the collaboration sector and Nanome
-
Dr. Zoran Radić, a UC San Diego scientific researcher, uses VR to explore treatments to a deadly nerve agent
For most of his career, Radić has analyzed AChE using traditional methods. But in the last three years, a virtual reality tool by San Diego company Nanome has allowed his research to leap forward. With Nanome’s VR tool, he can – virtually – manipulate AChE, study its interactions with other molecules, present his research in a more accessible and visible way, even collaborate with other researchers remotely in the VR space.
About Nanome
Nanome is the first virtual reality software company to launch an immersive real-time collaboration platform for scientific discovery, and is changing the way we understand and interact with science at the molecular level. The software environment allows users to visualize, modify, and simulate proteins, chemical compounds, and nucleic acids to accelerate scientific decision making. The platform facilitates effective communication of data and integrates with existing computational chemistry workflows—features that have led to the adoption of the San Diego–based company's enterprise solution by several pharmaceutical and biotech companies worldwide.
Download Nanome for free today.
Affiliates + Partnerships
